Prenetics Global (PRE) Total Non-Current Liabilities (2021 - 2026)
Prenetics Global (PRE) posted quarterly Total Non-Current Liabilities of $28.6 million for Q1 2026, up 1414.54% year-over-year from $1.9 million in Q1 2025, and up 13204.72% quarter-over-quarter from $215262.0 in Q4 2025.
Prenetics Global (PRE) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Total Non-Current Liabilities for 6 consecutive years, with $28.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 1414.54% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $28.6 million (up 1414.54% YoY), while the FY2025 annual figure was $21.0 million, up 269.74% from the prior year.
- Total Non-Current Liabilities rose to $28.6 million in Q1 2026 per PRE's latest filing, from $215262.0 in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $521.1 million in Q1 2022 and bottomed at $63939.6 in Q4 2024.
- Historically, Total Non-Current Liabilities has averaged $37.4 million across 5 years, with a median of $6.4 million in 2024.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities plunged 98.59% — and 2026, when it surged 1414.54%.
- Prenetics Global's Total Non-Current Liabilities stood at $11.5 million in 2022, then sank by 60.53% to $4.5 million in 2023, then plunged by 98.59% to $63939.6 in 2024, then soared by 236.66% to $215262.0 in 2025, then surged by 13204.72% to $28.6 million in 2026.
- Business Quant data shows PRE's Total Non-Current Liabilities at $28.6 million in Q1 2026, $215262.0 in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Prenetics Global | 368.73 Mn | 309.68 Mn | 30.20 Mn | 24.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.17 Mn |
| Mar 31, 2026 | 28.64 Mn |
| Dec 31, 2025 | 215,262.03 |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 63,939.61 |
| Sep 30, 2024 | 6.35 Bn |
| Jun 30, 2024 | 4.02 Bn |
| Mar 31, 2024 | 3.60 Bn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 7.29 Bn |
| Jun 30, 2023 | 8.60 Bn |
| Mar 31, 2023 | 9.70 Bn |
| Dec 31, 2022 | 11.47 Bn |
| Sep 30, 2022 | 12.79 Bn |
| Jun 30, 2022 | 11.97 Bn |
| Mar 31, 2022 | 521.09 Bn |
| Dec 31, 2021 | 490.66 Bn |